Ovarian tumors associated with multiple endocrine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hippel-Lindau disease, Cowden's disease)

International Journal of Gynecological Cancer

Volumn 12, Issue 4, 2002, Pages 337-347

  Papageorgiou, T ^a   Stratakis, C A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Carney complex; Cowden disease; Genetics; Multiple endocrine neoplasias; Ovarian cancer; Ovarian tumors; Peutz Jeghers syndrome

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

CARCINOID; CARNEY COMPLEX; COWDEN SYNDROME; DISEASE ASSOCIATION; FEMALE; HUMAN; MOLECULAR GENETICS; MULTIPLE ENDOCRINE NEOPLASIA; ONCOGENE K RAS; OVARY CARCINOMA; OVARY TUMOR; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

FEMALE; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA; OVARIAN NEOPLASMS;

EID: 0036321766     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01147.x     Document Type: Review

References (112)

1. The biology of ovarian cancer
2. Genetics and ovarian carcinoma
3. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation
4. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene
5. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
6. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review
7. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis
8. Hereditary ovarian cancer: A clinicopathological study
9. Characteristics of familial ovarian cancer: A report of the first 1,000 families in the Gilda Radner Familial Ovarian Cancer Registry
10. Clinical and pathological features of ovarian cancer in women with germline mutations of BRCA1
11. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer
12. p53 gene mutations and protein accumulation in human ovarian cancer
13. Mutation of K-ras proto-oncogene in human ovarian epithelial tumors of border line malignancy
14. Expression and amplification of the HER-2/neu (c-reb-2) protooncogene in epithelial ovarian tumors and cell lines
15. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas
16. Overxpression and amplification of the c-rebB-2 (Her 2/neu) protooncogene in epithelial ovarian tumors and cell lines
17. Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors
18. c-myc overexpression in human primary ovarian tumours: Its relevance to tumour progression
19. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
20. CSF-1 and C-FMS gene expression in human carcinoma cell lines
21. The role of PTEN, a phosphatase gene, in inherited and sporadic nonmedullary thyroid tumors
22. Cushing syndrome and Addison disease
23. A concise genetic and clinical guide to multiple endocrine neoplasias and related syndromes
24. Genetic aspects of adenomatosis of endocrine glands
25. Multiple endocrine neoplasia type I. Clinical and genetic topics
26. Multiple endocrine neoplasia type 2A associated with cutaneous lichen amyloidosis
27. Positional cloning of the gene for multiple endocrine neoplasia-type 1
28. Multiple endocrine neoplasia type 1. New clinical and basic findings
29. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes
30. Mutations of the RET protooncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease
31. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease
32. Genetic testing in medullary thyroid carcinoma syndromes. Mutation types and clinical significance
33. Familial form of Hirschsprung disease: Nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes
34. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease
35. Ectopic insulin production by a primary ovarian carcinoid
36. Ovarian strumal carcinoid in association with multiple endocrine neoplasia, type IIA
37. Carcinoids associated with multiple endocrine neoplasia syndromes
38. The complex of myxomas, spotty pigmentation, and endocrine overactivity
39. Clinical and genetic analysis of bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome
40. Primary pigmented nodular adrenocortical disease and its associated conditions
41. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex
42. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex
43. Ovarian cysts in patients with the Corney complex: Clinical genetics and possible predisposition to malignancy
44. Primary adrenocortical micronodular adenomatosis causing Cushing's syndrome. Effects of ketoconazole on steroid production and in vitro performance of adrenal cells
45. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits
46. Peutz-Jeghers syndrome. Risks of a hereditary condition
47. The molecular basis and clinical aspects of Peutz-Jeghers syndrome
48. Peutz-Jeghers syndrome. A clinicopathologic survey of the 'Harrisburg family' with a 49-year follow up
49. Cancer in Peutz-Jeghers syndrome
50. Increased risk for cancer in patients with the Peutz-Jeghers syndrome
51. Localisation of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis
52. Peutz-Jeghers disease: Most, but not all, families are compatible with linkage to 19p13.3
53. Peutz-Jeghers syndrome. Confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4
54. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome
55. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase
56. Genetic heterogeneity in Peutz-Jeghers syndrome
57. Sex cord tumor with annular tubules. A distinctive ovarian tumor of the Peutz-Jeghers syndrome
58. Peutz-Jeghers syndrome: Case presentation
59. A distinctive ovarian sex-core stromal tumor causing sexual precocity in the Peutz-Jeghers syndrome
60. Female genital tract and Peutz-Jeghers syndrome: An immunohistochemical study
61. Peutz-Jeghers syndrome with ovarian sex-cord tumor with annular tubules and cervical adenoma malignum
62. Un cas de syndrome de Peutz-Jeghers associé à un carcinoma mammaire bilatéral, à un adénocarcinome du col utérin et à des tumeurs des cordons sexuels à tubules annelés bilatérales dans les ovaires
63. Ovarian sex cord tumor with annular tubules. Review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix
64. Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome
65. Peutz-Jeghers syndrome with 'adenoma malignum' of the cervix. A report of two cases
66. Pelvic neoplasia in Peutz-Jeghers syndrome
67. Ovarian sex cord tumor with annular tubules and Peutz-Jeghers syndrome
68. Female genital tract tumors in Peutz-Jeghers syndrome
69. Malignant ovarian sex cord tumors with annular tubules in a patient with Peutz-Jeghers syndrome: A case report
70. Oxyphilic Sertoli cell tumor of the ovary: A report of three cases, two in patients with the Peutz-Jeghers syndrome
71. Peutz-Jeghers syndrome associated with precocious puberty
72. Sertoli cell tumor causing precocious puberty in a girl with Peutz-Jeghers syndrome
73. A poorly differentiated Sertoli-Leydig cell tumour associated with an ovarian sex cord tumour with annular tubules in a woman with Peutz-Jeghers syndrome
74. Mucinous ovarian tumors associated with mucinous adenocarconomas of the cervix
75. Ovarian tumors and Peutz-Jeghers syndrome
76. Ovarian tumors associated with the Peutz-Jeghers
77. The Peutz-Jeghers syndrome. Is there a predisposition to the development of malignancy?
78. Melanosi de Peutz-Jeghers associata a tumore ovarico presentazione di un caso
79. Peutz-Jeghers syndrome. A clinicopathologic study of a large family with a 27-year follow-up
80. Peutz-Jegh ers syndrome with colonic adenocarcinoma and ovarian tumor
81. Gastrointestinal polyposis with mucocutaneous pigmentation (Peutz-Jeghers syndrome)
82. Tumeur mucineuse ovarienne de type gastrique et intestinal associée au syndrome de Peutz-Jeghers; étude en hybridation in situ des transcrits des gènes d'apomucines
83. Identification of the von Hippel-Lindau (VHL) gene
84. Identification of the von Hippel-Lindau disease tumor suppressor gene
85. Renal involvement in von Hippel-Lindau disease
86. Molecular genetic analysis of von Hippel-Lindau disease
87. Cowden disease. Report of a family and review
88. The Cowden syndrome. A clinical and genetic study in 21 patients
89. Cowden syndrome
90. Cowden syndrome
91. Cowden's disease
92. Association of Lhermitte-Duclos and Cowden disease: Report of a new case and review of the literature
93. Localization of the gene for Cowden disease to chromosome 10q22-23
94. Genetics of Cowden syndrome: Through the looking glass of oncology
95. Mutations of the human PTEN gene
96. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
97. Tumeurs neuro-endocrines du pancréas et maladie de von Hippel-Lindau
98. Papillary cystadenoma of the mesosalpinx in von Hippel-Lindau disease
99. Cowden-Syndrom mit einem Ovarial-tumor (Multiple-Hamartome-Syndrom)
100. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer
101. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours
102. Mutational analysis of STK11 gene in ovarian carcinomas
103. Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome
104. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors
105. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies
106. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer
107. Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers
108. Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary
109. Single mutations of the PTEN gene in recurrent ovarian carcinomas
110. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: Possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary
111. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation
112. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways